1Public Health Ontario,Toronto,Canada.
4Institute for Clinical Evaluative Sciences,Toronto,Canada.
Infect Control Hosp Epidemiol. 2018 Aug;39(8):941-946. doi: 10.1017/ice.2018.121. Epub 2018 Jun 12.
Antibiotic use varies widely between hospitals, but the influence of antimicrobial stewardship programs (ASPs) on this variability is not known. We aimed to determine the key structural and strategic aspects of ASPs associated with differences in risk-adjusted antibiotic utilization across facilities.
Observational study of acute-care hospitals in Ontario, Canada METHODS: A survey was sent to hospitals asking about both structural (8 elements) and strategic (32 elements) components of their ASP. Antibiotic use from hospital purchasing data was acquired for January 1 to December 31, 2014. Crude and adjusted defined daily doses per 1,000 patient days, accounting for hospital and aggregate patient characteristics, were calculated across facilities. Rate ratios (RR) of defined daily doses per 1,000 patient days were compared for hospitals with and without each antimicrobial stewardship element of interest.
Of 127 eligible hospitals, 73 (57%) participated in the study. There was a 7-fold range in antibiotic use across these facilities (min, 253 defined daily doses per 1,000 patient days; max, 1,872 defined daily doses per 1,000 patient days). The presence of designated funding or resources for the ASP (RRadjusted, 0·87; 95% CI, 0·75-0·99), prospective audit and feedback (RRadjusted, 0·80; 95% CI, 0·67-0·96), and intravenous-to-oral conversion policies (RRadjusted, 0·79; 95% CI, 0·64-0·99) were associated with lower risk-adjusted antibiotic use.
Wide variability in antibiotic use across hospitals may be partially explained by both structural and strategic ASP elements. The presence of funding and resources, prospective audit and feedback, and intravenous-to-oral conversion should be considered priority elements of a robust ASP.
抗生素的使用在医院之间存在很大差异,但抗菌药物管理计划(ASPs)对这种差异的影响尚不清楚。我们旨在确定与设施间风险调整后抗生素使用差异相关的 ASP 的关键结构和战略方面。
对加拿大安大略省的急性护理医院进行观察性研究。
向医院发送了一份调查,询问其 ASP 的结构(8 个要素)和战略(32 个要素)组成部分。从医院采购数据中获取 2014 年 1 月 1 日至 12 月 31 日的抗生素使用情况。根据医院和综合患者特征,计算了每个设施的每千名患者天的原始和调整后的定义日剂量。比较了有和没有每个感兴趣的抗菌药物管理要素的医院之间每千名患者天的定义日剂量比。
在 127 家符合条件的医院中,有 73 家(57%)参与了这项研究。这些医院的抗生素使用范围相差 7 倍(最小值为每千名患者天 253 个定义日剂量;最大值为每千名患者天 1872 个定义日剂量)。ASP 有指定的资金或资源(调整后的 RR,0.87;95%CI,0.75-0.99)、前瞻性审核和反馈(调整后的 RR,0.80;95%CI,0.67-0.96)和静脉到口服转换政策(调整后的 RR,0.79;95%CI,0.64-0.99)与较低的风险调整后抗生素使用相关。
医院间抗生素使用的广泛差异可能部分归因于 ASP 的结构和战略要素。资金和资源的存在、前瞻性审核和反馈以及静脉到口服的转换应被视为强大 ASP 的优先要素。